Community Pharmacy Industry News

Independent pharmacists are busy serving their customers, care for their patients, and running their business. Keeping up with the latest industry news can be difficult. TDS compiles the latest news and important information for community pharmacists in one place, so you can always stay in the know. With links to valuable resources, you can find all of the information you need without having to search.

FDA Authorizes Pfizer-BioNTech COVID-19 Vaccine for Emergency Use in Children 5 through 11 Years of Age

Today, the U.S. Food and Drug Administration authorized the emergency use of the Pfizer-BioNTech COVID-19 Vaccine for the prevention of COVID-19 to in...

Read Post

CDC Statement on ACIP Booster Recommendations

CDC Director Rochelle P. Walensky, M.D., M.P.H., endorsed the CDC Advisory Committee on Immunization Practices’ (ACIP) recommendation for a booster sh...

Read Post

Pharmacists Granted Authority to Order and Administer Certain COVID-19 Therapeutics

The 9th amendment to the COVID-19 PREP Act Declaration provides liability immunity to and expands the scope of authority for licensed pharmacists to o...

Read Post

FDA grants Pfizer COVID-19 vaccine full approval

Today, the U.S. Food and Drug Administration approved the first COVID-19 vaccine. The vaccine has been known as the Pfizer-BioNTech COVID-19 Vaccine, ...

Read Post

WEBINAR: Additional mRNA COVID-19 Vaccines for Moderately to Severely Immunocompromised People

COCA Webinar: Presenters will discuss the current data on COVID-19 vaccines in immunocompromised people; the role of additional doses of mRNA COVID-19...

Read Post

Coronavirus (COVID-19) Update: FDA Authorizes Additional Vaccine Dose for Certain Immunocompromised Individuals

the U.S. Food and Drug Administration amended the emergency use authorizations (EUAs) for both the Pfizer-BioNTech COVID-19 Vaccine and the Moderna CO...

Read Post

FDA announces shelf-life extension for J&J vaccine

The FDA authorized an extension of shelf life for the Johnson & Johnson’s Janssen COVID-19 vaccine from 4.5 months to 6 months, an additional 45 days....

Read Post

States Step Up Push to Regulate Pharmacy Drug Brokers

Under pressure to rein in skyrocketing prescription drug costs, states are targeting companies that serve as conduits for drug manufacturers, health i...

Read Post

NCPA to Congress: Pharmacy Needs Provider Status

On Tuesday, NCPA urged Congress to pass provider status legislation, S. 1362 - the Pharmacy and Medically Underserved Areas Enhancement Act at a heari...

Read Post

OSHA Releases New Requirements for Health Care Settings

OSHA released an emergency temporary standard to reduce the risk that healthcare workers may contract COVID-19 in the workplace. This does not apply t...

Read Post

Big News from Medicare on Vaccination Reimbursement

Medicare has added an additional payment of $35 for administering the COVID-19 vaccine in homes for Medicare patients who have a difficult time leavin...

Read Post

FDA’s Decision to Approve New Treatment for Alzheimer’s Disease

Today FDA approved Aduhelm (aducanumab) to treat patients with Alzheimer’s disease using the Accelerated Approval pathway, under which the FDA approve...

Read Post

Interested in learning why TDS is the leader in pharmacy solutions?

Our team is dedicated to the community pharmacy industry. Let us show you the difference a true partner can make.  

Get Started